Tamoxifen and Combination Chemotherapy as Adjuvant Treatment in Postmenopausal Women with Breast Cancer
- 1 January 1984
- book chapter
- Published by Springer Nature
- Vol. 96, 197-203
- https://doi.org/10.1007/978-3-642-82357-2_25
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Adjuvant systemic therapy in breast cancer; a reviewEuropean Journal of Cancer and Clinical Oncology, 1983
- IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCERThe Lancet, 1983
- Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year resultsBreast Cancer Research and Treatment, 1983
- Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim reportBreast Cancer Research and Treatment, 1983
- Adjuvant therapy of breast cancer: The Southwest Oncology Group experienceBreast Cancer Research and Treatment, 1983
- Adjuvant radiotherapy in operable breast cancer: Correlation between dose in internal mammary nodes and prognosisInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975